News
06-03-2012, 11:23 PM
GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.
More... (http://www.news-medical.net/news/20120604/Study-shows-valuable-role-of-Mammostrat-in-assessing-ER2b-postmenopausal-breast-cancer-patients.aspx)
More... (http://www.news-medical.net/news/20120604/Study-shows-valuable-role-of-Mammostrat-in-assessing-ER2b-postmenopausal-breast-cancer-patients.aspx)